Jamie Capal, MD
Dr. Jamie Capal earned her undergraduate degree at Ithaca College and her medical degree at Albany Medical College before completing her pediatrics and pediatric neurodevelopmental disabilities training at Cincinnati Children’s Hospital Medical Center.
Dr. Capal is currently an assistant professor on staff at Cincinnati Children’s Hospital, where she is involved in clinical and research focused on children with autism spectrum disorders and related neurodevelopmental conditions. As noted on the CCHMC website, “A natural extension of her research has led to interest in tuberous sclerosis complex (TSC), where autism, abnormal EEG, and seizures are frequent and interdependent. The genetic and molecular basis of TSC is well established, which provides an ideal platform for further investigation into the underlying mechanisms responsible and, in turn, discover new molecular-based targeted therapies.”
Dr. Cappal is a member of the Child Neurology Society and the American Academy of Neurology. Dr. Capal, along with Drs. Sarah Spence and Evdokia Anagnostou presented a “Neuroscience in the Clinic” session, “Autism Myth Busters” at the 2018 AAN Annual Meeting in Los Angeles, and graciously set aside time afterward to tape insightful comments to share with her child neurology colleagues on the CNS website.
Sarah Spence, MD, PhD
Sarah Spence, MD, PhD is an Assistant Professor in the Department of Neurology, Boston Children’s Hospital, Harvard Medical School where she also serves as Co-Director of the Autism Spectrum Center. Dr. Spence completed undergraduate training in psychobiology at Harvard Radcliffe College before going on to earn her PhD in behavioral neuroscience at UCLA and her MD at the University of California San Franciso. She completed pediatrics and pediatric neurology training at UCLA.
Her professional interests are outlined nicely in a profile posted on the BCH website (http://www.childrenshospital.org/directory/physicians/s/sarah-spence)
“Dr Spence’s clinical and research activities have been focused on children with Autism Spectrum Disorders (ASD) and related disorders. She was recruited to BCH in 2010 and has led a multi-disciplinary effort to form the Autism Spectrum Center at BCH, of which she is co-director.
As a child neurologist with doctoral training in cognitive neuroscience, her research interests have always been at the interface between brain and behavior. She credits her ASD expertise to the experience of doing home visits for the Autism Genetic Resource Exchange (AGRE), a large autism genebank. She spent 6 years as the medical director of the UCLA Autism Evaluation Clinic and then 4 years at the National Institute of Mental Health (NIMH) doing clinical research. At Boston Children’s she is combining her interests and expertise in clinical care, clinical research, and teaching with a primary focus on improving the lives of children with autism spectrum disorders and their families.
She has lectured extensively nationally and internationally on ASD. She has also worked on the DSM-5 Neurodevelopmental Disabilities Workgroup and worked with various foundations and professional groups including Cure Autism Now, Autism Speaks, AGRE, the Autism Treatment Network, the Dup 15q Alliance, the Tuberous Sclerosis Alliance.”
Dr. Spence has been very active in both the Child Neurology Society and the American Academy of Neurology, effectively demonstrating the value to her career, her colleagues, her patients, and to the medical associations to which she belongs by being actively involved in multiple professional organizations.
Edvokia Anagnostou, MD
Dr. Evdokia Anagnostou is a senior clinician scientist and co-lead of the Autism Research Centre at Holland Bloorview Kids Rehabilitation Hospital with an academidc appointment as associate professor in the Department of Pediatrics at the University of Toronto. Dr. Anagnostou is a founding member of Kids Brain Health’s autism research group.
Dr. anagnostou completed her undergraduate and medical degrees, as well as her neurology training at McGill University, before going on to a postdoctoral fellowship in Autism/Developmental Disabilities at Mount Sinai School of Medicine in 2005. Dr. Anagnostou joined Holland Bloorview Kids Rehabilitation Hospital in 2008 and subsequently became involved as the lead investigator in the Province of Ontario Neurodevelopmental Disorders (POND) network and the Canada Research Chair (Tier II) in Translational Therapeutics in Autism. In 2016, she was appinted as the inaugural Dr. Stuart D. Sims Chair in Autism.
Dr. Anagnostou, along with Drs. Sarah Spence and Jamie Capal presented a “Neuroscience in the Clinic” session, “Autism Myth Busters” at the 2018 AAN Annual Meeting in Los Angeles, and graciously set aside time afterward to tape insightful comments to share with her child neurology colleagues on the CNS website.